Claim OwnershipEndocrine Deep Dives
Subscribed: 7Played: 107
Subscribe
© Gurbir Gill, MD
Description
The Endocrine Deep Dive covers advanced topics in endocrinology. Utilizing AI-driven synthetic audio discussions from my own study notes, each episode breaks down complex endocrine concepts.
Comprehensive Legal & Medical Disclaimer: Endocrine Deep Dives and all associated content, materials, and digital assets are produced strictly for informational and educational purposes only. The program is intended solely for healthcare providers, medical fellows, residents, and students as a supplement to their professional training.
No Physician-Patient Relationship: Listening to this podcast, accessing show notes, or interacting with the platform does not establish a physician-patient, pharmacist-patient, or any other formal professional-client relationship between the host and any listener or patient.
Not Medical Advice: The content does not constitute individualized medical advice, clinical diagnosis, or treatment recommendations. Patients and members of the general public must never use this content to guide personal healthcare decisions and must always consult a qualified, licensed physician or healthcare provider for any medical concerns.
Clinical Responsibility: Healthcare professionals listening to this program must exercise their own independent clinical judgment. The host's interpretations, study notes, and opinions reflect personal perspectives on literature and do not set an official standard of care. Clinicians bear sole responsibility for verifying all pharmacological dosing, diagnostic criteria, and treatment protocols against official institutional guidelines, current primary literature, and individual patient presentation.
Limitation of Liability: The host, creators, and associated entities disclaim any and all liability for direct, indirect, incidental, or consequential damages resulting from the use, misuse, application, or interpretation of any information presented in this podcast. Reliance on any data or opinion provided is solely at the listener's own risk.
Comprehensive Legal & Medical Disclaimer: Endocrine Deep Dives and all associated content, materials, and digital assets are produced strictly for informational and educational purposes only. The program is intended solely for healthcare providers, medical fellows, residents, and students as a supplement to their professional training.
No Physician-Patient Relationship: Listening to this podcast, accessing show notes, or interacting with the platform does not establish a physician-patient, pharmacist-patient, or any other formal professional-client relationship between the host and any listener or patient.
Not Medical Advice: The content does not constitute individualized medical advice, clinical diagnosis, or treatment recommendations. Patients and members of the general public must never use this content to guide personal healthcare decisions and must always consult a qualified, licensed physician or healthcare provider for any medical concerns.
Clinical Responsibility: Healthcare professionals listening to this program must exercise their own independent clinical judgment. The host's interpretations, study notes, and opinions reflect personal perspectives on literature and do not set an official standard of care. Clinicians bear sole responsibility for verifying all pharmacological dosing, diagnostic criteria, and treatment protocols against official institutional guidelines, current primary literature, and individual patient presentation.
Limitation of Liability: The host, creators, and associated entities disclaim any and all liability for direct, indirect, incidental, or consequential damages resulting from the use, misuse, application, or interpretation of any information presented in this podcast. Reliance on any data or opinion provided is solely at the listener's own risk.
140 Episodes
Reverse
This episode reviews the differential diagnosis of paroxysmal adrenergic symptoms, contrasting sympathoadrenal hyperreactivity with catecholamine-secreting neuroendocrine tumors. We analyze the diagnostic utility and pre-test confounding factors of plasma versus fractionated urinary metanephrines, evaluate concurrent features of thyrotoxicosis, carcinoid syndrome, and mast cell activation, and outline evidence-based alpha-blockade protocols prior to surgical or medical intervention.
This episode evaluates postural orthostatic tachycardia syndrome, exploring neuroendocrine and autonomic dysregulation, including hyperadrenergic phenotypes and volume depletion. We examine diagnostic tilt-table criteria, the crucial exclusion of primary endocrine mimics such as pheochromocytoma and adrenal insufficiency, and evidence-based management strategies spanning fludrocortisone, nonselective beta-blockers, alpha-1 agonists, and structured physical reconditioning.
This episode examines subclinical hyperthyroidism, characterized by suppressed serum TSH alongside normal free thyroxine and triiodothyronine. We analyze etiology differentiation between autonomous nodular disease and Graves disease, risk stratification for atrial fibrillation and accelerated bone loss, and guideline thresholds for initiating antithyroid pharmacotherapy or definitive ablation in older adults and postmenopausal patients.
Pretest probability dictates the entire diagnostic workflow for Cushing syndrome by guiding appropriate patient selection for screening and preventing false positives from incidentalomas or physiological hypercortisolism. Because diagnostic tests carry distinct false-positive rates when applied to low-risk populations, initial biochemical evaluation must be strictly reserved for patients with recognizable clinical stigmata or progressive multisystem manifestations. Quantifying clinical probability prevents the diagnostic cascade of unindicated testing, ensuring that abnormal screening results reflect true autonomous cortisol excess rather than benign physiological mimics or stress-induced alterations.
Screening for primary aldosteronism requires measuring the aldosterone-to-renin ratio under standardized conditions, accounting for interfering antihypertensives and hypokalemia. Diagnosis hinges on non-suppressible autonomous aldosterone secretion via confirmatory suppression testing. Once confirmed, adrenal protocol cross-sectional imaging and adrenal vein sampling are essential to reliably differentiate unilateral surgically curable adenomas from bilateral idiopathic adrenal hyperplasia prior to targeted intervention.
Comments
Download from Google Play
Download from App Store
United States